Korea Health Industry Development Institute (KHIDI) logo
KHIDI Health Industry R&D Promotion (umbrella)

KHIDI Health Industry R&D Promotion (seed)

Funds South Korea innovation teams building health-device and drug pipelines from proof to commercialization.

The Korea Health Industry Development Institute (KHIDI) administers Health Industry R&D Promotion funding on behalf of the Ministry of Health and Welfare (MOHW), operating as Korea's specialist agency for planning, evaluation, and management of domestic healthcare R&D. The programme targets promising next-generation technologies across four primary verticals: innovative new drugs, medical devices,…

Funds Korean healthcare R&D across innovative new drugs, medical devices, regenerative medicine, and AI-enabled digital health through annual MOHW-budget calls managed by KHIDI.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Guides for this application

All guides →
European Commission logo
Scheduled

Horizon Health: Cell-Free Protein Synthesis Platforms

🇪🇺European Commission · European Union

Funds €6–8M projects that make cell-free protein synthesis practical for discovering and producing peptide- and protein-based biologicals.

BiotechMedtech
€6M – €8MApr'27
European Commission logo
Scheduled

Horizon Health: Bio-printing for Regenerative Medicine

🇪🇺European Commission · European Union

Funds €7–10M projects that advance living-cell bio-printing from laboratory proof toward regenerative medicine.

BiotechMedtech
€7M – €10MSep'27
European Commission logo
Scheduled

Innovative healthcare interventions for non-communicable diseases

🇪🇺European Commission · European Union

Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.

BiotechMedtech
€7M – €8MApr'27
Innovative Health Initiative Joint Undertaking (IHI JU) logo
Open

IHI European HealthCare Incubator Network

🇨🇦IHI JU · European Union

Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.

MedtechBiotech
€35MOct'26
European Commission logo
Scheduled

Horizon Health: Flavivirus Antibody Therapies

🇪🇺European Commission · European Union

Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.

BiotechMedtech
€9M – €10MApr'27
European Commission logo
Scheduled

Horizon Health: Antibody Therapies for Emerging Viruses

🇪🇺European Commission · European Union

Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.

BiotechMedtech
€9M – €10MApr'27